EYE ON CHINA
Abstract
Fosun Pharmaceutical and Shanghai drugs open innovation model.
QIAGEN gains SFDA approval to market careHPV Test.
AstraZeneca's heart drug wins approval.
SIMM explores a novel cationic core-shell lipo-nanoparticles for ocular gene drug delivery.
TaiGen and TTY Biopharm jointly develop and commercialize a novel topoisomerase I inhibitor for cancer treatment.
iHuman Institute inauguration held.
Sihuan Pharmaceutical collaborates with NeuroVive to develop two innovative cardio-cerebral vascular products.
PerkinElmer acquires China-based infectious disease diagnostics company.